Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Hydroxamic acid-based MMP inhibitors described by P&U

July 14, 1998

Anergen initiates clinical trials with AnergiX

July 14, 1998

Alexion initiates C5 inhibitor phase I/II clinical trial for rheumatoid arthritis

July 14, 1998

Collagenase inhibitors in the pipeline at British Biotech

July 13, 1998

Clinical trial results in RA reported for T-614

July 9, 1998

Mechanism of action of new antiarthritic drug KE-298

July 9, 1998

MX-68: mechanisms underlying antiinflammatory activity

July 9, 1998

Bone-sparing antiinflammatory benzamide under investigation at Daiichi

July 9, 1998

Vertex/Kissei select development candidate from p38 MAP kinase inhibitor program

July 8, 1998

Long-term safety and efficacy data presented for Enbrel

July 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...